Glycosylation-on-a-Chip: A Flow-Based Microfluidic System for Cell-Free Glycoprotein Biosynthesis
Alicia K Aquino1, Zachary A Manzer1, Susan Daniel1
1Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, United States.
Frontiers in Molecular Biosciences
|January 10, 2022
Summary
We developed a microfluidic platform for cell-free glycoprotein synthesis. This chip-based system optimizes protein production, glycosylation, and purification, improving yields for synthetic biology applications.
Area of Science:
- Synthetic biology
- Biotechnology
- Microfluidics
Background:
- Cell-free synthetic glycobiology enables glycoprotein production but often suffers from low yields due to competing reactions in one-pot systems.
- Existing cell-based and cell-free glycosylation systems lack spatiotemporal control.
- Microfluidic platforms offer advantages like reaction compartmentalization and enzyme reuse for improved biomanufacturing.
Purpose of the Study:
- To develop an integrated microfluidic platform for cell-free glycoprotein synthesis.
- To overcome limitations of current one-pot cell-free systems by optimizing individual reaction steps.
- To demonstrate a novel glycosylation-on-a-chip prototype for research and biomanufacturing.
Main Methods:
- Integration of cell-free protein synthesis, glycosylation, and purification in separate microfluidic compartments.
- Utilizing microfluidics for reaction compartmentalization, tunable residence times, and enzyme immobilization.
- Employing an immobilized oligosaccharyltransferase for efficient protein glycosylation.
Main Results:
- Demonstrated enhanced cell-free protein synthesis within the microfluidic platform.
- Achieved efficient protein glycosylation using immobilized enzymes.
- Successfully enriched the target glycoprotein product from the cell-free lysate.
Conclusions:
- The microfluidic platform enables optimized, compartmentalized cell-free glycoprotein synthesis.
- This glycosylation-on-a-chip system offers spatiotemporal control, overcoming limitations of existing methods.
- The prototype serves as a valuable tool for studying glycosylation and for decentralized biomanufacturing of glycoproteins.


